Lipid metabolomics to analyze the mechanisms for cellular adaptation to tumor microenvironment
Lipid metabolomics to analyze the mechanisms for cellular adaptation to tumor microenvironment
批准号:
22650230
负责人:
SEIMIYA Hiroyuki
金额:
$2.12万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011
中文摘要
癌细胞通常会增强脂质的从头合成。然而,其功能意义仍然未知。在这项研究中,我们发现一种叫做ATP柠檬酸裂解酶(ACLY)的脂质合成酶的耗尽会阻止癌细胞的生长。这种抗癌作用在活性氧(ROS)和AMPK磷酸化水平较低的细胞中更为明显。ACLY消耗升高棕榈酸的相对丰度。由于棕榈酸可以诱导ROS,它可能有助于ACLY消耗的抗癌作用。在临床结肠肿瘤中,较高的恶性等级与较低水平的AMPK磷酸化和氧化应激相关,表明ACLY抑制可用作抗癌治疗剂。
英文摘要
Cancer cells often enhance de novo lipid synthesis. However, its functional significance remains unknown. In this study, we found that depletion of a lipid-synthesizing enzyme, called ATP citrate lyase(ACLY), blocks cancer cell growth. This anticancer effect was more evident in those cells with lower reactive oxygen species(ROS) and lower phosphorylation level of AMPK. ACLY depletion elevated the relative abundance of palmitate. Because palmitate can induce ROS, it may contribute to the anticancer effect of ACLY depletion. In clinical colon tumors, higher malignant grades correlated with lower levels of AMPK phosphorylation and oxidative stress, suggesting that ACLY inhibition can be utilized as an anticancer therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1124/mol.110.064790
发表时间:
2010-11-01
期刊:
MOLECULAR PHARMACOLOGY
影响因子:
3.6
作者:
[Mashima, Tetsuo, Okabe, Sachiko, Seimiya, Hiroyuki]
通讯作者:
Seimiya, Hiroyuki
脂質代謝酵素を標的とした乳癌、前立腺癌の治療とその分子機構
脂质代谢酶靶向治疗乳腺癌和前列腺癌及其分子机制
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[右田敏郎, 岡部幸子, 清宮啓之]
通讯作者:
清宮啓之
A novel yeast cell-based screen identifies flavone as a tankyrase inhibitor
一种新型的基于酵母细胞的筛选将黄酮鉴定为坦科聚合酶抑制剂
DOI:
--
发表时间:
2010
期刊:
Biochem Biophys Res Commun 394
影响因子:
--
作者:
[遠藤玉樹, 宍戸昌彦, 大槻高史, Yashiroda Y]
通讯作者:
Yashiroda Y
Involvement of constitutively active truncated androgen receptor(tAR) in hormone-refractory prostate cancer growth and the tAR inhibition by nigericin
组成型活性截短型雄激素受体(tAR)参与激素难治性前列腺癌生长以及尼日利亚霉素对 tAR 的抑制
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Mashima T., Okabe S., Seimiya H.]
通讯作者:
Seimiya H.
DOI:
10.1016/j.stem.2010.06.003
发表时间:
2010-07-02
期刊:
CELL STEM CELL
影响因子:
23.9
作者:
[Seki, Tomohisa, Yuasa, Shinsuke, Fukuda, Keiichi]
通讯作者:
Fukuda, Keiichi
共 20 条
Molecular basis for cancer cell-specific vulnerability to disturbance of G-quadruplex dynamics
-
批准号:20K21555
-
项目类别:Grant-in-Aid for Challenging Research (Exploratory)
-
资助金额:$4.16万
-
财政年份:2020
-
负责人:SEIMIYA Hiroyuki
-
依托单位:
Optimization of cancer therapeutic strategies that target tankyrase-specific PARylation
-
批准号:19H03523
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.15万
-
财政年份:2019
-
负责人:SEIMIYA Hiroyuki
-
依托单位:
Bioinformatics-based functional analysis of telomeric non-coding RNA
-
批准号:24650639
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:SEIMIYA Hiroyuki
-
依托单位:
Development of cancer molecular therapeutics that targets telomere-regulating factors
-
批准号:22300341
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.98万
-
财政年份:2010
-
负责人:SEIMIYA Hiroyuki
-
依托单位:
Development of cancer molecular therapeutics directed to telomeres and cellular senescence svstems
-
批准号:20015047
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$11.52万
-
财政年份:2008
-
负责人:SEIMIYA Hiroyuki
-
依托单位:
Multi-functions of tankyrase-1 in carcinogenesis
-
批准号:19370078
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.81万
-
财政年份:2007
-
负责人:SEIMIYA Hiroyuki
-
依托单位:
海外基金